Treatment Advances Have Improved Multiple Myeloma Mortality in the US
Researchers sought to determine the mortality trends for patients with multiple myeloma over the past few decades.
Multiple Myeloma
Carvykti Approved for Relapsed/Refractory Multiple Myeloma
Carvykti is a B-cell maturation antigen (BCMA)-directed genetically modified autologous chimeric antigen receptor (CAR) T-cell therapy.
Heart Failure Tied to Increased Risk of Cancers, Cancer-Related Mortality
The excess risk of cancer appeared to be associated with the severity of heart failure.
Breakthrough COVID-19 May Be More Common in Patients With Lymphoid Malignancies
About 81% of patients had lymphoproliferative malignancies.
Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Darzalex Faspro, Pomalidomide, Dexamethasone Combo Approved for Multiple Myeloma
The approval was based on data from the phase 3 APOLLO trial.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
- Loading...
Loading...
Loading... 
Loading...